XML 115 R16.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

SHARE-BASED COMPENSATION | 12 Months Ended
--- | ---
Oct. 31, 2019
SHARE-BASED COMPENSATION [Abstract] |
SHARE-BASED COMPENSATION | NOTE 9 – SHARE-BASED COMPENSATION In March 2016, shareholders approved a new equity incentive compensation plan (“the Plan”), under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted. Shares to be issued under the Plan may be authorized and unissued shares, issued shares that have been reacquired by us (in the open-market or in private transactions), shares held in the treasury, or a combination thereof. The maximum number of shares of common stock approved that may be issued under the Plan is four million shares. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of Photronics or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan, aspects of which are more fully described below, prohibits further awards from being issued under prior plans. We incurred total share-based compensation expenses of $3.7 million, $3.2 million, and $3.6 million in fiscal years 2019, 2018, and 2017, respectively. No share-based compensation cost was capitalized as part of an asset and no related income tax benefits were recorded during the fiscal years presented. Stock Options Option awards generally vest in one to four years, and have a ten-year contractual term. All incentive and non-qualified stock option grants must have an exercise price no less than the market value of the underlying common stock on the date of grant. The grant-date fair values of options are based on closing prices of our common stock on the dates of grant and are calculated using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of our common stock. We use historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that options granted are expected to remain outstanding. The risk-free rate of return for the estimated term of an option is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options issued during fiscal years 2019, 2018 and 2017 are presented in the following table:
| Year Ended
| October 31, 2019 | October 31, 2018 | October 29, 2017
Expected volatility | 33.1% | 31.7% | 32.2%
Risk-free rate of return | 2.5 - 2.9% | 2.2 - 2.8% | 1.9 - 2.0%
Dividend yield | 0.0% | 0.0% | 0.0%
Expected term | 5.1 years | 5.0 years | 5.0 years
The table below presents a summary of stock options activity during fiscal year 2019 and information on stock options outstanding at October 31, 2019.
Options |  | Shares |  |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Life |  | Aggregate Intrinsic Value |
Outstanding at October 31, 2018 |  |  | 2,423,560 |  |  | $ | 8.68 |  |  |  |  |
Granted |  |  | 132,000 |  |  | $ | 9.77 |  |  |  |  |
Exercised |  |  | (322,010 | ) |  | $ | 6.43 |  |  |  |  |
Cancelled and forfeited |  |  | (62,783 | ) |  | $ | 11.47 |  |  |  |  |
Outstanding at October 31, 2019 |  |  | 2,170,767 |  |  | $ | 9.00 |  | 5.4 years |  | $ | 6,206 |
Exercisable at October 31, 2019 |  |  | 1,615,225 |  |  | $ | 8.61 |  | 4.6 years |  | $ | 5,242 |
Vested and expected to vest as of October 31, 2019 |  |  | 2,095,804 |  |  | $ | 8.95 |  | 5.3 years |  | $ | 6,096 |
The weighted-average grant date fair value of options granted during fiscal years 2019, 2018 and 2017 were $3.31, $2.76 and $3.59, respectively. The total intrinsic value of options exercised during fiscal years 2019, 2018 and 2017 was $1.3 million, $2.5 million and $1.9 million, respectively. We received cash from option exercises of $2.1 million, $4.3 million and $2.4 million in fiscal years 2019, 2018 and 2017, respectively. As of October 31, 2019, the total unrecognized compensation cost of unvested option awards was approximately $0.9 million. That cost is expected to be recognized over a weighted-average amortization period of 2.1 years. Restricted Stock We periodically grant restricted stock awards, the restrictions on which typically lapse over a service period of one to four years. The fair value of an award is the closing stock price of our common stock on the date of grant. There were 435,000, 290,000, and 317,750 restricted stock awards granted during fiscal years, 2019, 2018 and 2017, respectively. The weighted-average grant date fair values of those awards were $9.80, $8.62 and $10.94. The total fair value of awards for which restrictions lapsed was $1.9 million, $1.4 million and $1.2 million during fiscal years 2019, 2018 and 2017, respectively. As of October 31, 2019, the total compensation cost for restricted stock awards not yet recognized was approximately $4.3 million. That cost is expected to be recognized over a weighted-average amortization period of 2.6 years. A summary of restricted stock award activity during fiscal year 2019 and the status of our outstanding restricted stock awards as of October 31, 2019, is presented below:
Restricted Stock |  | Shares |  |  | Weighted-Average Fair Value at Grant Date |
Outstanding at October 31, 2018 |  |  | 419,297 |  |  | $ | 9.58 |
Granted |  |  | 435,000 |  |  | $ | 9.80 |
Vested |  |  | (195,684 | ) |  | $ | 9.65 |
Cancelled |  |  | (18,500 | ) |  | $ | 9.82 |
Outstanding at October 31, 2019 |  |  | 640,113 |  |  | $ | 9.70 |
Expected to vest as of October 31, 2019 |  |  | 594,771 |  |  | $ | 9.69 |
Employee Stock Purchase Plan Our Employee Stock Purchase Plan (“ESPP”) permits employees to purchase Photronics, Inc. common shares at 85% of the lower of the closing market price at the commencement or ending date of the Plan year (which is approximately one year). We recognize the ESPP expense during that same period. As of October 31, 2019, the maximum number of shares of common stock approved by our shareholders to be purchased under the ESPP was 1.85 million shares, of which approximately 1.5 million shares had been issued through October 31, 2019; No shares were subject to outstanding subscriptions as of October 31, 2019.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration